The convergence of rising cannabis legalization and persistent tobacco use creates an unprecedented challenge for maternal health, as animal research reveals both substances fundamentally reprogram fetal development through shared epigenetic pathways. This mechanistic overlap suggests pregnancy exposures may compound risks in ways traditional single-substance studies have missed. Controlled animal studies demonstrate that prenatal THC exposure disrupts neurodevelopment and alters cardiovascular and metabolic systems in offspring, with effects varying by sex and persisting into adulthood. Nicotine produces parallel but distinct damage patterns across pulmonary, neurological, and renal systems. The critical discovery involves epigenetic modifications—particularly DNA methylation changes—that serve as the molecular bridge between exposure and long-term health consequences. These epigenetic marks effectively "remember" the prenatal insult, potentially explaining why developmental exposures create lifelong vulnerabilities. The research landscape faces mounting complexity as cannabis products diversify beyond traditional forms and co-use patterns emerge among pregnant women. Current human studies struggle with confounding variables like socioeconomic factors and polysubstance use, making animal models essential for isolating direct causal mechanisms. The findings suggest a paradigm shift from viewing prenatal substance exposure as temporary developmental disruption to recognizing it as permanent biological reprogramming. This epigenetic framework opens new prevention strategies targeting the molecular machinery of developmental programming rather than solely focusing on behavioral interventions during pregnancy.